#bloodcancer
Revlimid Price Comparison Highlights US-India Cancer Drug Cost Gap
A viral Revlimid price comparison between the United States and India has renewed discussion about cancer drug costs, generic medicines and patient access. In an Instagram video posted by the account Spicy Gori, an American woman claimed that one Revlimid pill costs about $900 in the United States. She said she found options in India ranging from approximately Rs 35 to Rs 300 per pill, which she estimated at about 30 cents to $3. In an
Revlimid Price Comparison Highlights US-India Cancer Drug Cost Gap
A viral Revlimid price comparison between the United States and India has renewed discussion about cancer drug costs, generic medicines and patient access. In an Instagram video posted by the account Spicy Gori, an American woman claimed that one Revlimid pill costs about $900 in the United States. She said she found options in India ranging from approximately Rs 35 to Rs 300 per pill, which she estimated at about 30 cents to $3. In an
Medical Miracle: DNA Base Editing Cures Previously Incurable Blood Cancer
Scientists have achieved a historic medical breakthrough by successfully curing a form of blood cancer that was long considered incurable. Researchers from University College London and Great Ormond Street Hospital have used a revolutionary technology known as DNA base editing to treat T-cell acute lymphoblastic leukaemia, a rare and aggressive cancer that primarily affects children and young adults. This marks the first time base-edited cells have been used in humans to achieve long-term can
Medical Miracle: DNA Base Editing Cures Previously Incurable Blood Cancer
Scientists have achieved a historic medical breakthrough by successfully curing a form of blood cancer that was long considered incurable. Researchers from University College London and Great Ormond Street Hospital have used a revolutionary technology known as DNA base editing to treat T-cell acute lymphoblastic leukaemia, a rare and aggressive cancer that primarily affects children and young adults. This marks the first time base-edited cells have been used in humans to achieve long-term can









